Durable response in the markers of cholestasis through 5 years of open-label extension study of obeticholic acid in primary biliary cholangitis
Nevens, F., Shiffman, M.L., Drenth, J.P.H., Bowlus, C.L., Vargas, V., Andreone, P., van Erpecum, K., Floreani, A., Liberman, A., Pencek, R., Malecha, E. Smoot, MacConell, L., Trauner, M.
Published in Digestive and liver disease (01.02.2020)
Published in Digestive and liver disease (01.02.2020)
Get full text
Journal Article
Risk reduction with obeticholic acid in patients not achieving the POISE primary endpoint
Harms, M, Carbone, M, Hansen, B, Mells, G, Pencek, R, Smoot-Malecha, E, MacConell, L
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
PC.01.3: Efficacy and Safety of Obeticholic Acid in Patients with Primary Biliary Cholangitis: An Analysis of the Italian Patients from a Phase 3, Randomized, Placebo-Controlled Study
Floreani, A, Andreone, P, Invernizzi, P, Mazzella, G, Owens-Grillo, J, Smoot Malecha, E, Macconell, L
Published in Digestive and liver disease (15.03.2017)
Published in Digestive and liver disease (15.03.2017)
Get full text
Journal Article
Durable response in the markers of cholestasis through 24 months of open-label extension with obeticholic acid in Italian patients with primary biliary cholangitis
Andreone, P, Floreani, A, Invernizzi, P, Mazzella, G, Owens-Grillo, J, Smoot Malecha, E, MacConell, L
Published in Digestive and liver disease (16.02.2017)
Published in Digestive and liver disease (16.02.2017)
Get full text
Journal Article
T06.01.3 DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 5 YEARS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS
Nevens, F., Mitchell, S., Drenth, J.P., Bowlus, C.L., Vargas, V., Andreone, P., Van Erpecum, K., Floreani, A., Lieberman, A., Pencheck, R., Smoot Malecha, E.
Published in Digestive and liver disease (01.10.2020)
Published in Digestive and liver disease (01.10.2020)
Get full text
Journal Article
Durable response in the markers of cholestasis through 36 months of open-label extension with obeticholic acid in Italian patients with primary biliary cholangitis
Andreone, P., Floreani, A., Invernizzi, P., Mazzella, G., Owens-Grillo, J., Malecha, E. Smoot, MacConell, L.
Published in Digestive and liver disease (01.02.2018)
Published in Digestive and liver disease (01.02.2018)
Get full text
Journal Article
A200 AN INTEGRATED ANALYSIS OF EFFICACY OF OBETICHOLIC ACID IN CANADIAN PATIENTS
Mason, A, Vincent, C, Aspinall, A, Swain, M, Hirschfield, G M, Minuk, G, Shah, H, Owens-Grillo, J, Malecha, E Smoot, MacConell, L
Published in Journal of the Canadian Association of Gastroenterology (01.03.2018)
Published in Journal of the Canadian Association of Gastroenterology (01.03.2018)
Get full text
Journal Article